Statistical Analysis Sample size calculations were performed at the beginning of this exploratory trial ( n = 40)
This includes proposed up-regulation of endothelial nitric oxide synthase (NOS3), decreased stimulation of endothelial cells, development of anti-oxidative responses, decreased migration of inflammatory cells, decreased antigen presentation because of suppressed MHC II expression in endothelial cells [57] resulting from promoter IV of class II trans-activator (CIITA) [58], down-regulation of pro-inflammatory cytokines, decreased PLT accumulation, development of 15-epi-lipoxin (15-epi-LXB4), which operates through preventing the signaling pathways engaged in the stimulation of the inflammatory response induced by lipid agents [59, 60] and, finally, enhanced migration, differentiation, and prohibitory functions of Treg cells [59, 61]
Inflammatory cytokines, such as IL-6, IL-17, and IL-23, also decreased after KD
Early trials of AOD-9604 showed promising results
It is a peptide the body produces in response to metabolic demand and that declines when that capacity is impaired
